975 results on '"Hort, Jakub"'
Search Results
2. CSF neurogranin levels as a biomarker in Alzheimer’s disease and frontotemporal lobar degeneration: a cross-sectional analysis
3. Predicting progression from subjective cognitive decline to mild cognitive impairment or dementia based on brain atrophy patterns
4. Grey matter networks in women and men with dementia with Lewy bodies
5. Mild behavioral impairment in early Alzheimer’s disease and its association with APOE and BDNF risk genetic polymorphisms
6. Integrating AI in fighting advancing Alzheimer: diagnosis, prevention, treatment, monitoring, mechanisms, and clinical trials
7. Spatial navigation questionnaires as a supportive diagnostic tool in early Alzheimer’s disease
8. Spatial navigation is associated with subcortical alterations and progression risk in subjective cognitive decline
9. MRI data-driven clustering reveals different subtypes of Dementia with Lewy bodies
10. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
11. The reliability of a deep learning model in clinical out-of-distribution MRI data: a multicohort study
12. The measured CSF/plasma donepezil concentration ratio but not individually measured CSF and plasma concentrations significantly increase over 24 h after donepezil treatment in patients with Alzheimer’s disease
13. Reconfiguration of brain network dynamics underlying spatial deficits in subjective cognitive decline
14. Digital biomarkers and sex impacts in Alzheimer’s disease management — potential utility for innovative 3P medicine approach
15. New insights into the genetic etiology of Alzheimer’s disease and related dementias
16. Emotional prosody recognition is impaired in Alzheimer’s disease
17. Six genetically linked mutations in the CD36 gene significantly delay the onset of Alzheimer's disease
18. Strukturální MR zobrazení mozku u pacientů s Alzheimerovou nemocí/hodnocení ARIA – úvodní praktické informace.
19. Cerebrovascular disease, neurodegeneration, and clinical phenotype in dementia with Lewy bodies
20. Ego- and allo-network disconnection underlying spatial disorientation in subjective cognitive decline
21. ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer’s disease
22. Alterations of human CSF and serum-based mitophagy biomarkers in the continuum of Alzheimer disease.
23. Plasminogen activator inhibitor‐1 serum levels in frontotemporal lobar degeneration
24. Magnetic resonance markers of bilateral neuronal metabolic dysfunction in patients with unilateral internal carotid artery occlusion
25. Sex differences in brain atrophy in dementia with Lewy bodies
26. Levels of Mitophagy Biomarkers Differ Between Individuals With Alzheimer’s disease and Frontotemporal Lobar Degeneration
27. Differentiation of clinically diagnosed patients with aMCI and dementia from cognitively unimpaired older adults using plasma and serum p‐tau 181 and NfL
28. Mitophagy biomarkers are changed in the continuum of Alzheimer’s disease
29. Spatial navigation performance differentiates Alzheimer´s disease biomarker positive and biomarker negative cognitively impaired older adults
30. Plasma protein profiling reveals novel specific biomarkers reflecting the multifactorial nature of Alzheimer´s disease continuum
31. Psychometric Characteristics of the Novel Subjective Cognitive Changes Questionnaire (SCC‐Q) in Older Adults at Risk of Dementia
32. Basal forebrain nuclei volume is associated with hematoencephalic barrier dysfunction in early Alzheimer’s disease
33. Regional brain atrophy is associated with measures of impaired blood‐CSF barrier in patients with prodromal and overt dementia with Lewy bodies and Alzheimer’s disease dementia
34. Mild behavioral impairment in prodromal Alzheimer´s disease and its association with APOE and BDNF risk genetic polymorphisms
35. The molar ratio between PAI‐1 and BDNF is increased in Alzheimer’s disease patients with full dementia and negatively correlates with MMSE score
36. DIFFERENTIAL MRI ATROPHY PROFILES IN OLDER ADULTS WITHOUT DEMENTIA FROM AGING STUDIES IN THE US AND CZECH REPUBLIC
37. Specific memory binding indexes and their potential to discriminate between Alzheimer´s disease biomarker‐positive and biomarker‐negative older adults with amnestic mild cognitive impairment
38. Plasma pTau181 and biomarker combinations to identify Alzheimer´s disease at any stage along the AD continuum compared with both controls and non‐AD dementia
39. The Pattern of Hippocampus and Entorhinal Cortex Subregion Atrophy in Early Alzheimer’s Disease
40. An update on mobile phone applications collecting data among subjects with or at risk of dementia
41. Comparison between self‐ and informant‐rated versions of the Mild behavioral impairment checklist in patients with mild cognitive impairment
42. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
43. Interactions of 17β-Hydroxysteroid Dehydrogenase Type 10 and Cyclophilin D in Alzheimer's Disease
44. A signature pattern of cortical atrophy in dementia with Lewy bodies: A study on 333 patients from the European DLB consortium
45. Sex differences in brain atrophy in dementia with Lewy bodies.
46. Transferability of a European-derived Alzheimer’s Disease Genetic Risk Score across Multi-Ancestry Populations
47. Serum PAI-1/BDNF Ratio Is Increased in Alzheimer’s Disease and Correlates with Disease Severity
48. Corrigendum to “The measured CSF/plasma donepezil concentration ratio but not individually measured CSF and plasma concentrations significantly increase over 24 h after donepezil treatment in patients with Alzheimer’s disease” [Biomed. Pharmacother. 159 (2023) 114223]
49. The effect of Alzheimer's disease on spatial navigation strategies
50. Costs of dementia in the Czech Republic
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.